Role of 12-lipoxygenase in Platelet Reactivity and Type 2 Diabetes Mellitus

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
ThrombosisType 2 Diabetes Mellitus
Interventions
DIETARY_SUPPLEMENT

Primrose oil

T2DM patients and matched controls subjects will be given Primrose oil for 2 months, followed by 2-week washout. Blood will be drawn at the beginning, during, and following treatments and platelet function will be assessed.

DIETARY_SUPPLEMENT

Fish Oil

T2DM patients and matched controls subjects will be given Fish oil for 2 months, followed by 2-week washout. Blood will be drawn at the beginning, during, and following treatments and platelet function will be assessed.

Trial Locations (1)

48109

University of Michigan, Ann Arbor

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Michigan

OTHER

NCT02629497 - Role of 12-lipoxygenase in Platelet Reactivity and Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter